As filed with the Securities and Exchange Commission on October 26, 2005    

                                                     Registration No. 333-128225
--------------------------------------------------------------------------------


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                               AMENDMENT NO. 1 TO
                                    FORM F-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933


                        MER TELEMANAGEMENT SOLUTIONS LTD.
             (Exact name of Registrant as specified in its charter)

             Israel                                    Not Applicable
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
 incorporation or organization)

                        MER TELEMANAGEMENT SOLUTIONS LTD.
                                22 Zarhin Street
                             Ra'anana 43662, Israel
                             Tel: (972)(9) 762-1777
                             Fax: (972) (9) 746-6596
   (Address and telephone number of Registrant's principal executive offices)

                            -------------------------

                              MTS IntegraTRAK, Inc.
                        12600 S.E. 38th Street Suite 250
                           Belleview, Washington 98006
                               Tel: (425)401-1711
                               Fax: (425)401-1700

            (Name, address and telephone number of agent for service)

                            -------------------------

     Copies of all  communications,  including  communications sent to agent for
service, should be sent to:

               Dan Alon, Adv.                     Steven J. Glusband, Esq.
             M. Seligman & Co.                  Carter Ledyard & Milburn LLP
              24 Rambam Street                          2 Wall Street
           Tel Aviv 61040, Israel                    New York, NY 10005
             Tel: 972-3-516-2661                     Tel: 212-238-8605
             Fax:+972-3-516-2668                     Fax: 212-732-3232



Approximate date of commencement of proposed sale to the public: From time to
time after the effective date of this Registration Statement.

If the only securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. [ ]

If any of the securities being registered on this form are to be offered on a 
delayed or continuous basis pursuant to Rule 415 under the Securities Act of 
1933, please check the following box. [X]








If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]

If delivery of the prospectus is expected to be made pursuant to Rule 436,
please check the following box. [ ]



                              ---------------------

         The Registrant hereby amends this Registration Statement on such date
or dates as may be necessary to delay its effective date until the Registrant
shall file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.

                              ---------------------




The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.



                  SUBJECT TO COMPLETION, DATED OCTOBER 26, 2005                


PROSPECTUS

                        MER TELEMANGEMENT SOLUTIONS LTD.

                            1,349,500 ORDINARY SHARES

         This prospectus relates to up to 1,349,500 ordinary shares that the
selling shareholders named in this prospectus or their transferees may offer
from time to time. Of the ordinary shares offered hereby, (i) 937,500 ordinary
shares were issued to certain of the selling shareholders, and 375,000 ordinary
shares are issuable upon the exercise of warrants that were issued to them,
pursuant to a securities purchase agreement dated as of August 10, 2005; and
(ii) 37,000 ordinary shares are issuable upon exercise of a warrant issued to
Mr. Avraham Ziv on August 3, 2005 in connection with financial services he has
provided to our company. We are registering the ordinary shares for disposition
by the selling shareholders pursuant to commitments with the selling
shareholders. The registration of the ordinary shares does not necessarily mean
that the selling shareholders or their transferees will offer or sell their
shares.

         We will not receive any of the proceeds from the sale by the selling
shareholders of the ordinary shares offered by this prospectus, and will bear
all expenses in connection with the preparation of this prospectus.


         Our ordinary shares are listed for trading on the NASDAQ Capital Market
under the symbol "MTSL." On October 25, 2005, the closing price of our ordinary
shares on the NASDAQ Capital Market was $3.48.                                


         See "Risk Factors" beginning on page 6 to read about factors you should
consider before buying the ordinary shares of our company.

                                ----------------

         Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a
criminal offense.



                        Prospectus dated       2005












                                TABLE OF CONTENTS


Notice Regarding Forward-Looking Statements...................................3
Prospectus Summary............................................................4
Risk Factors..................................................................6
Capitalization And Indebtedness..............................................18
Reasons For The Offer And Use Of Proceeds....................................19
Market Price Data............................................................19
Selling Shareholders.........................................................20
Offer Statistics, Expected Time Table And Plan Of Distribution...............23
Expenses Associated With The Registration....................................25
Foreign Exchange Controls And Other Limitations..............................26
Experts......................................................................26
Legal Matters................................................................27
Material Changes.............................................................27
Where You Can Best Find More Information; Incorporation Of Certain 
Information By Reference.....................................................27
Enforceability Of Civil Liabilities..........................................29



         When you are deciding whether to purchase the ordinary shares being
offered by this prospectus, you should rely only on the information incorporated
by reference or provided in this prospectus or any supplement. We have not
authorized anyone to provide you with different information. We are not making
any offer of the ordinary shares in any state where the offer is not permitted.
You should not assume that the information in this prospectus or any supplement
is accurate as of any date other than the date on the front of those documents.

         In this prospectus, "we," "us," "our," the "Company" and "Mer
Telemanagement Solutions" refer to Mer Telemanagement Solutions Ltd., an Israeli
company.

         We are a "foreign private issuer" as defined in Rule 3b-4 under the
Securities Exchange Act of 1934, or the Exchange Act. As a result, our proxy
solicitations are not subject to the disclosure and procedural requirements of
Regulation 14A under the Exchange Act and transactions in our equity securities
by our officers and directors are exempt from Section 16 of the Exchange Act. In
addition, we are not required under the Exchange Act to file periodic reports
and financial statements as frequently or as promptly as United States companies
whose securities are registered under the Exchange Act.

         We publish annually an annual report on our website containing
financial statements that have been examined and reported on, with an opinion
expressed by, a registered accounting firm. Our financial statements in U.S.
dollars and in accordance with accounting principles generally accepted in the
United States. All references to "dollars" or "$" in this prospectus are to U.S.
dollars, and all references to "shekels" or "NIS" are to New Israeli Shekels.



                                        2






                   NOTICE REGARDING FORWARD-LOOKING STATEMENTS

         This prospectus and the documents incorporated in it by reference
contain forward-looking statements which involve known and unknown risks and
uncertainties. We include this notice for the express purpose of permitting us
to obtain the protections of the safe harbor provided by the Private Securities
Litigation Reform Act of 1995 with respect to all such forward-looking
statements. Examples of forward-looking statements include: projections of
capital expenditures, competitive pressures, revenues, growth prospects, product
development, financial resources and other financial matters. You can identify
these and other forward-looking statements by the use of words such as "may,"
"will," "should," "plans," "anticipates," "believes," "estimates," "predicts,"
"intends," "potential" or the negative of such terms, or other comparable
terminology.

         Our ability to predict the results of our operations or the effects of
various events on our operating results is inherently uncertain. Therefore, we
caution you to consider carefully the matters described under the caption "Risk
Factors" and certain other matters discussed in this prospectus, the documents
incorporated by reference in this prospectus, and other publicly available
sources. Such factors and many other factors beyond the control of our
management could cause our actual results, performance or achievements to be
materially different from any future results, performance or achievements that
may be expressed or implied by the forward-looking statements.

                                       3






                               PROSPECTUS SUMMARY

         You should read the following summary together with the more detailed
information about us, the ordinary shares that may be sold from time to time,
and our financial statements and the notes to them, all of which appear
elsewhere in this prospectus or in the documents incorporated by reference in
this prospectus.

                        MER TELEMANAGEMENT SOLUTIONS LTD.

         We were incorporated under the laws of the State of Israel in December
1995 and are a public limited liability company under the Israeli Companies Law
5739-1999 and operate under such law and associated legislation. Our registered
offices and principal place of business are located at 22 Zarhin Street,
Ra<180>anana 43662, Israel, and our telephone number is 972-9-762-1777. Our
address on the Internet is www.mtsint.com. The information on our website is not
incorporated by reference into this prospectus.

         We are a total solutions provider in the telecom expense and billing
arenas. We design, develop, market and support a comprehensive line of
telecommunication management, expense management and customer care and billing,
or CC&B, solutions that enable business organizations and other enterprises to
more effectively manage and optimize the use of their communication resources.
Our products include call accounting and management products, fault management
systems and Web-based management solutions for converged voice, voice over IP,
or VoIP, IP data and video and CC&B solutions. These products are designed to
provide telecommunication and information technology managers with tools to
reduce communication costs, recover charges payable by third parties, detect and
report the abuse and misuse of telephone networks, monitor and detect hardware
and software faults in telecommunications networks and generate
telecommunications usage information for use in the management of an enterprise.
We were among the first to offer PC-based call accounting systems when we
introduced our TABS product in 1985. To date, over 60,000 TABS call accounting
systems have been sold to end-users in more than 60 countries. In addition,
approximately 1,000 WinTrak systems (which we acquired from IntegraTRAK, Inc. in
April 2000) have been sold in the United States market since 1985. Although we
are no longer marketing WinTRAK, we continue to support this product.

                                  The Offering

Ordinary shares offered.................   1,349,500 shares (including 412,000 
                                           shares issuable upon exercise of 
                                           warrants)
Ordinary Shares Outstanding.............   4,786,004 ordinary shares


Nasdaq Capital Market Symbol............   "MTSL"



                                       4






Use of proceeds.........................   We will not receive any proceeds from
                                           the sale of the ordinary shares 
                                           offered hereby.  We will, however,
                                           receive the proceeds from the 
                                           exercise of the warrants if and when
                                           they are exercised for cash.

Risk Factors............................   Prospective investors should 
                                           carefully consider the Risk Factors
                                           beginning on Page 6 before buying
                                           the ordinary shares offered hereby.



                                       5






                                  RISK FACTORS

         You should carefully consider the risks and uncertainties described
below before investing in our ordinary shares. Our business, prospects,
financial condition and results of operations could be adversely affected due to
any of the following risks. In that case, the value of our ordinary shares could
decline, and you could lose all or part of your investment.

Risks Relating to Our Business and Market

We have had a recent history of operating  losses and may not achieve or sustain
profitability in the future.

         We have incurred operating losses in each of the five last fiscal years
and we cannot assure you that we will be able to achieve or sustain profitable
operations in the future. To the extent that we continue to incur operating
losses, we may not have sufficient working capital to fund our operations in the
future. If we do not generate sufficient cash from operations, we will be
required to obtain additional financing or reduce level of expenditure. There
can be no assurance that such financing will be available in the future, or, if
available, will be on terms satisfactory to us.

Our operating results fluctuate significantly.

         Our quarterly results have fluctuated significantly in the past and are
likely to fluctuate significantly in the future. Our future operating results
will depend on many factors, including, but not limited to the following:

          o    demand for our products;

          o    changes in our pricing policies or those of our competitors;

          o    the number, timing and significance of product enhancements;

          o    new product announcements by us and our competitors;

          o    our ability to  develop,  introduce  and market new and  enhanced
               products on a timely basis;

          o    changes in the level of our operating expenses;

          o    budgeting cycles of our customers;

          o    customer order  deferrals in  anticipation of enhancements or new
               products that we or our competitors offer;

          o    product life cycles;

          o    changes in our strategy;


                                        6








          o    seasonal trends and general domestic and  international  economic
               and political conditions, among others; and

          o    currency  exchange rate  fluctuations and economic  conditions in
               the geographic areas where we operate.

         Due to the foregoing factors, quarterly revenues and operating results
are difficult to forecast, and it is likely that our future operating results
will be adversely affected by these or other factors.

         Revenues are also difficult to forecast because the market for
telecommunication management solutions is rapidly evolving and our sales cycle,
from initial evaluation to purchase, is lengthy and varies substantially from
customer to customer. We typically ship product orders shortly after receipt of
a purchase order and, consequently, order backlog at the beginning of any
quarter has in the past represented only a small portion of that quarter's
revenues. As a result, license revenues in any quarter depend substantially on
orders booked and shipped in that quarter.

         Due to all of the foregoing, we cannot predict revenues for any future
quarter with any significant degree of accuracy. Accordingly, we believe that
period-to-period comparisons of our operating results are not necessarily
meaningful and you should not rely upon them as indications of future
performance. Although our revenues increased in 2004 and the first six months of
2005, our revenues declined in each of the years from 1999 to 2003 and we cannot
assure you that we will be able to sustain revenue growth in the future.

Our operating results vary quarterly and seasonally.

         We have often recognized a substantial portion of our revenues in the
last quarter of the year and in the last month, or even weeks or days, of a
quarter. Our expense levels are substantially based on our expectations for
future revenues and are therefore relatively fixed in the short term. If revenue
levels fall below expectations, our quarterly results are likely to be
disproportionately adversely affected because a proportionately smaller amount
of our expenses varies with our revenues.

         Our operating results are generally not characterized by a seasonal
pattern, except that our sales in Europe are generally lower in the summer
months. Due to the foregoing, in some future quarter, our operating results may
be below the expectations of public market analysts and investors. In such
event, it is likely that the price of our ordinary shares would be materially
and adversely affected.

We depend on the market for telemanagement  products,  which market has declined
in recent years.

         In recent years we have derived substantially all of our revenues from
our TABS.IT call accounting and billing products. We have implemented a new
strategy that has led to the development and introduction of our Application
Suite. The Application Suite is built on the Microsoft.Net platform and
establishes a framework for us to provide customized solutions that include
customer care and billing, in addition to the traditional telemanagement
solutions. The main functions of our TABS.IT and the WinTrak family of products
were incorporated into the



                                       7






Application Suite. Our future financial performance will depend, in significant
part, on the successful development, introduction, marketing and customer
acceptance of the Application Suite and related telemanagement products. Except
for a slight increase in revenues in the 2004 fiscal year and the increase in
revenues in the six months ended June 30, 2005, our revenues have declined each
year since 1999 and there can be no assurance that the market for these products
will grow in the future. If the market for the our telemanagement products fails
to return to previous levels, or grows more slowly than we currently anticipate,
our business, operating results and financial condition would be materially and
adversely affected.

We depend on business telephone system  manufacturers,  vendors and distributors
for our sales.

         One of the primary distribution channels for our call accounting
management products are private branch exchange, or PBX, original equipment
manufacturers, or OEMs, and vendors who market our products to end-users in
conjunction with their own products. We have entered into partnership agreements
with each of NEC and Avaya for the integration of our products with their own
products and the marketing of the integrated product. Sales by PBX manufacturers
and vendors have declined markedly in the recent past, and no assurance can be
given that sales through this channel will recover. Our success will be
dependent to a substantial degree on the marketing and sales efforts of such
third parties in marketing and integrating our products. There can be no
assurance that these third parties will give priority to the sale of our
products as an enhancement to their products. Although most of the major
business telephone switching systems manufacturers and vendors currently rely on
third-party suppliers to provide call accounting and other telemanagement
products, no assurance can be given that these manufacturers and vendors,
including our current customers, will not develop their own competing products
or purchase competing products from others.

         We are highly dependent upon the active marketing and distribution
efforts of our PBX OEM's. In 2002, 2003, 2004, and the six months ending June
30, 2005, our three major OEMs, Siemens Gmbh, Philips Communications Systems
B.V. and Ericsson, generated 46.0%, 51.0%, 47.0% and 39.0% of our consolidated
revenues, respectively. The percentage of sales attributable to each of these
OEMs in each of the three years ended December 31, 2004 and the six months
ending June 30, 2005 are as follows:


                                                              Six months ended
                            2002         2003        2004       June 30, 2005 
                            ----         ----        ----       ------------- 
Siemens.................    36.0%        40.0%       38.0%          33.0%
Philips.................     6.0%         7.0%        5.0%           4.0%
Ericsson................     4.0%         4.0%        4.0%           2.0%

         Because we sell our products through local master distributors in
countries where we do not have a marketing subsidiary, we are highly dependent
upon the active marketing and distribution efforts of our distributors. We also
depend in large part upon our distributors for product maintenance and support.
There can be no assurance that our distributors will continue to provide
adequate maintenance and support to end-users or will provide maintenance and
support for new products, which might cause us to seek new or additional
distributors or incur additional


                                       8




service and support costs. The distributors to whom we sell our products are
generally not contractually required to make future purchases of our products
and could, therefore, discontinue carrying our products at any time. None of our
distributors or resellers are subject to any minimum purchase requirements under
their agreements with us. There can be no assurance that we will continue our
relationships with our OEM customers or, if such relationships are not
maintained, that we would be able to attract and retain comparable PBX original
equipment manufacturers. The loss of any of our major reseller or OEM
relationships, either to competitive products offered by other companies or
products developed by such resellers, would have a material adverse effect on
our business, financial condition and results of operations. Our future
performance will depend, in part, on our ability to attract additional PBX
manufacturers and vendors that will be able to market and support our products
effectively, especially in markets in which we have not previously distributed
our products.

We have recently acquired certain assets of Teleknowledge  Group Ltd., and there
can be no assurance that we will successfully integrate their products.

         In December 2004, we completed the acquisition of certain assets and
liabilities of Teleknowledge Group Ltd., or Teleknowledge, a provider of carrier
class billing and related solutions. The acquisition of the Teleknowledge
billing solution enables us to offer an end-to-end customer care and billing
solution, including pre/post paid billing, Web self-care, assets management,
partner management, help desk and order management modules. These products offer
a complimentary solution to our own products. There can be no assurance that we
will successfully integrate the Teleknowledge products into our products.

We face  risks  associated  with  expanding  and  maintaining  our  distribution
network.

         We sell our products through distributors, business telephone switching
systems manufacturers and vendors, post, telephone and telegraph authorities, or
PTTs and our direct sales force. Our ability to achieve revenue growth in the
future will depend in large part on our success in establishing and maintaining
relationships with business telephone switching systems manufacturers and
vendors and PTTs, establishing and maintaining relationships with distributors,
and recruiting and training additional direct sales personnel. We plan to invest
significant resources to expand our direct sales force and to develop new
distribution relationships. Historically, we have at times experienced
difficulty in recruiting qualified sales personnel and in establishing effective
distribution relationships. There can be no assurance that we will be able to
successfully expand our direct sales force or other distribution channels or
that any such expansion will result in an increase in revenues. The failure to
expand or maintain our direct sales force or other distribution channels could
have a material adverse effect on our business, operating results and financial
condition.

We are subject to risks associated with international operations.

         We are based in Israel and generate a large percentage of our sales
outside the United States. Our sales in the United States accounted for 66.0%,
53.0%, 53.0% and 55.0% of our total revenues for the years ended December 31,
2002, 2003 and 2004, and the six months ended June 30, 2005, respectively.
Although we continue to expand our international operations and commit
significant management time and financial resources to developing direct and
indirect

                                       9






international sales and support channels, we cannot be certain that we will be
able to maintain or increase international market demand for our products. To
the extent that we cannot do so in a timely manner, our business, operating
results and financial condition will be materially and adversely affected.

         International operations are subject to inherent risks, including the
following:

          o    the impact of  possible  recessionary  environments  in  multiple
               foreign markets;

          o    costs of localizing products for foreign markets;

          o    longer  receivables  collection periods and greater difficulty in
               accounts receivable collection;

          o    unexpected changes in regulatory requirements;

          o    difficulties   and  costs  of  staffing  and   managing   foreign
               operations;

          o    reduced  protection  for  intellectual  property  rights  in some
               countries;

          o    potentially adverse tax consequences; and

          o    political and economic instability.

         We cannot be certain that we, our distributors or resellers will be
able to sustain or increase revenues from international operations or that the
foregoing factors will not have a material adverse effect on our future revenues
and, as a result, on our business, operating results and financial condition.

         We may be adversely affected by fluctuations in currency exchange
rates. While our revenues are generally denominated in U.S. dollars and Euros, a
significant portion of our expenses are incurred in NIS. We do not currently
engage in any currency hedging transactions intended to reduce the effect of
fluctuations in foreign currency exchange rates on our results of operations. If
we were to determine that it was in our best interests to enter into any hedging
transactions in the future, there can be no assurance that we will be able to do
so or that such transactions, if entered into, will materially reduce the effect
of fluctuations in foreign currency exchange rates on our results of operations.
In addition, if, for any reason, exchange or price controls or other
restrictions on the conversion of foreign currencies into NIS were imposed, our
business could be adversely affected. Although exposure to currency fluctuations
to date has not had a material adverse effect on our business, there can be no
assurance such fluctuations in the future will not have a material adverse
effect on revenues from international sales and, consequently, on our business,
operating results and financial condition.

We  are  subject  to  risks  relating  to   proprietary   rights  and  risks  of
infringement.

         We are dependent upon our proprietary software technology and we rely
primarily on a combination of copyright and trademark laws, trade secrets,
confidentiality procedures and contractual provisions to protect our proprietary
rights. We try to protect our software,

                                       10






documentation and other written materials under trade secret and copyright laws,
which afford only limited protection. It is possible that others will develop
technologies that are similar or superior to our technology. Despite our efforts
to protect our proprietary rights, unauthorized parties may attempt to copy
aspects of our products or to obtain and use information that we regard as
proprietary. It is difficult to police the unauthorized use of our products, and
we expect software piracy to be a persistent problem, although we are unable to
determine the extent to which piracy of our software products exists. In
addition, the laws of some foreign countries do not protect our proprietary
rights as fully as do the laws of the United States. We cannot be certain that
our means of protecting our proprietary rights in the United States or abroad
will be adequate or that our competition will not independently develop similar
technology.

         We are not aware that we are infringing upon any proprietary rights of
third parties. It is possible, however, that third parties will claim
infringement by us of their intellectual property rights. We believe that
software product developers will increasingly be subject to infringement claims
as the number of products and competitors in our industry segment grows and the
functionality of products in different industry segments overlaps. It would be
time consuming for us to defend any such claims, with or without merit, and any
such claims could:

          o    result in costly litigation;

          o    divert management's attention and resources;

          o    cause product shipment delays; or

          o    require us to enter into  royalty or licensing  agreements.  Such
               royalty  or  licensing  agreements,   if  required,  may  not  be
               available on terms acceptable to us, if at all.

         If there is a successful claim of product infringement against us and
we are not able to license the infringed or similar technology, our business,
operating results and financial condition would be materially and adversely
affected.

         We rely upon certain software that we license from third parties,
including software that we integrate with our internally developed software. We
cannot be certain that these third-party software licenses will continue to be
available to us on commercially reasonable terms. If we lose or are unable to
maintain any such software licenses, we could suffer shipment delays or
reductions until equivalent software could be developed, identified, licensed
and integrated, which would materially and adversely affect our business,
operating results and financial condition.

We may be unsuccessful in our defense of pending litigation.

         On April 18, 2005, Amdocs (Israel) Ltd. and Amdocs Ltd. filed a
complaint in the Tel Aviv District Court naming our company, our chief executive
officer and others as defendants (Civil File No. 32419-05/05). The complaint
alleges, among other things, that professional and commercial information
belonging to the plaintiffs was transferred to the defendants for use in our
company's activity. The plaintiffs are seeking an injunction prohibiting the
defendants from making any use of the information and trade secrets that were
allegedly transferred, and mandatory injunctions requiring the return of any
such information and the payment of estimated


                                       11






damages of NIS 14,775,000 (approximately US$3.3 million). On June 27, 2005, the
defendants filed a statement of defense, claiming that the factual and legal
allegations made by the plaintiffs have no basis, and the causes of action and
relief requested are without merit. Due to the preliminary stage of the
litigation proceeding, we cannot currently advise as to the outcome of the
lawsuit. We intend to vigorously defend this action, however, there can be no
assurance that we will be successful.

Our results may be adversely affected by competition.

         The market for telemanagement products is fragmented and is intensely
competitive. Competition in the industry is generally based on product
performance, depth of product line, technical support and price. We compete both
with international and local competitors (including providers of
telecommunications services), many of whom have significantly greater financial,
technical and marketing resources than us. We anticipate continuing competition
in the telemanagement products market and the entrance of new competitors into
the market. Our existing and potential customers, including business telephone
switching system manufacturers and vendors, may be able to develop
telemanagement products and services that are as effective as, or more effective
or easier to use than, those offered by us. Such existing and potential
competitors may also enjoy substantial advantages over us in terms of research
and development expertise, manufacturing efficiency, name recognition, sales and
marketing expertise and distribution channels. There can be no assurance that we
will be able to compete successfully against current or future competitors or
that competition will not have a material adverse effect on our future revenues
and, consequently, on our business, operating results and financial condition.

We are subject to risks  associated  with rapid  technological  change and risks
associated with new versions and new products.

         The telecommunications management market in which we compete is
characterized by rapid technological change, introductions of new products,
changes in customer demands and evolving industry standards. Our future success
will depend upon our ability to keep pace with the technological developments
and to timely address the increasingly sophisticated needs of our customers by
supporting existing and new telecommunication technologies and services and by
developing and introducing enhancements to our current and new products. There
can be no assurance that we will be successful in developing and marketing
enhancements to our products that will respond to technological change, evolving
industry standards or customer requirements, that we will not experience
difficulties that could delay or prevent the successful development,
introduction and sale of such enhancements or that such enhancements will
adequately meet the requirements of the marketplace and achieve any significant
degrees of market acceptance. If release dates of any new products or
enhancements are delayed or, if when released, they fail to achieve market
acceptance, our business, operating results and financial condition would be
materially and adversely affected. In addition, the introduction or announcement
of new product offerings or enhancements by us or our competitors may cause
customers to defer or forgo purchases of current versions of our product, which
could have a material adverse effect on our business, operating results and
financial condition.



                                       12






We may not be able to retain or attract key  managerial,  technical and research
and development personnel we need to succeed.

         Our success has largely depended and will depend in the future on our
skilled professional and technical employees, substantially all of whom have
written employment agreements. The competition for these employees is intense.
We may not be able to retain our present employees, or recruit additional
qualified employees as we require them.

Three of our  shareholders  are in a position  to control  matters  requiring  a
shareholder vote.

         Mr. Chaim Mer, our Chairman, and his wife, Dora Mer, our Israeli
counsel, currently control the vote of approximately 34.9% of our outstanding
ordinary shares, and Isaac Ben-Bassat, one of our directors, is the owner of
12.02% of our outstanding ordinary shares.

         As a result, such persons control and will continue to control the
election of our entire Board of Directors other than our two outside directors
and generally have the ability to direct our business and affairs.

We are subject to risks  arising  from  product  defects and  potential  product
liability.

         We provide free warranty and support for up to one year for end-users
and up to 15 months for our OEM distributors. Our sales agreements typically
contain provisions designed to limit our exposure to potential product liability
or related claims. The limitation of liability provisions contained in our
agreements may not be effective. Our products are used by businesses to reduce
communication costs, recover charges payable by third parties and prevent abuse
and misuse of telephone networks and, as a result, the sale of products by us
may entail the risk of product liability and related claims. A product liability
claim brought against us could have a material adverse effect upon our business,
operating results and financial condition. Products such as those offered by us
may contain undetected errors or failures when first introduced or when new
versions are released. Despite our testing and testing by current and potential
customers, there can be no assurance that errors will not be found in new
products or releases after commencement of commercial shipments. The occurrence
of these errors could result in adverse publicity, loss of or delay in market
acceptance or claims by customers against us, any of which could have a material
adverse effect upon our business, operating results and financial condition.

The  implementation  of  SFAS  No.  123(R),  which  will  require  us to  record
compensation  expense in connection  with equity share based  compensation as of
the first quarter of 2006, may reduce our profitability.

         On December 16, 2004, the Financial Accounting Standards Board, or 
FASB, issued Statement No. 123 (revised 2004), Share-Based Payment, or SFAS No. 
123(R), which is a revision of SFAS No. 123.  Generally, the approach in SFAS 
No. 123(R) is similar to the approach described in SFAS No. 123.  However, SFAS 
No. 123 permitted, but did not require, share-based payments to employees
to be recognized on the basis of their fair values while SFAS No. 123(R) 
requires, as of the first quarter of 2006, all share-based payments to employees
to be recognized on the basis of their fair values.  SFAS No. 123(R) also 
revises, clarifies and expands guidance in several areas, including measuring 
fair value, classifying an award as equity or as a liability and attributing
compensation cost to reporting periods.  The adoption of SFAS No. 123(R) may 
have a


                                       13






significant effect on our results of operations in the future; however, the
impact of its adoption cannot be predicted at this time. In addition, such
adoption could limit our ability to use stock options as an incentive and
retention tool, which could, in turn, negatively impact our ability to recruit
employees and retain existing employees. However, had we adopted SFAS 123(R) in
prior periods, the impact of that standard would have approximated the impact of
SFAS No. 123 as described in the disclosure of pro forma net income and earnings
per share in our consolidated financial statements.

Risk Factors Related to Our Ordinary Shares

We are classified as a passive foreign investment  company,  or PFIC, which will
subject our U.S. investors to adverse tax rules.

         Holders of our ordinary shares who are United States residents face
income tax risks. There is a substantial risk that we are a passive foreign
investment company, commonly referred to as PFIC. Our treatment as a PFIC could
result in a reduction in the after-tax return to the holders of our ordinary
shares and would likely cause a reduction in the value of such shares. For U.S.
Federal income tax purposes, we will be classified as a PFIC for any taxable
year in which either (i) 75% or more of our gross income is passive income, or
(ii) at least 50% of the average value of all of our assets for the taxable year
produce or are held for the production of passive income. For this purpose, cash
is considered to be an asset, which produces passive income. As a result of our
relatively substantial cash position at the time, we believe that we became a
PFIC in 2004 under a literal application of the asset test described above,
which looks solely to the market value. If we are classified as a PFIC for U.S.
federal income tax purposes, highly complex rules would apply to U.S. Holders
owning ordinary shares. Accordingly, you are urged to consult your tax advisors
regarding the application of such rules.

Our share price has been volatile in the past and may decline in the future.

         Our ordinary shares have experienced significant market price and
volume fluctuations in the past and may experience significant market price and
volume fluctuations in the future in response to factors such as the following,
some of which are beyond our control:

          o    quarterly variations in our operating results;

          o    operating  results that vary from the  expectations of securities
               analysts and investors;

          o    changes in expectations as to our future  financial  performance,
               including   financial   estimates  by  securities   analysts  and
               investors;

          o    announcements of technological  innovations or new products by us
               or our competitors;

          o    announcements by us or our competitors of significant  contracts,
               acquisitions,  strategic partnerships,  joint ventures or capital
               commitments;

          o    changes in the status of our intellectual property rights;


                                       14






          o    announcements   by  third  parties  of   significant   claims  or
               proceedings against us;

          o    additions or departures of key personnel;

          o    future sales of our ordinary shares; and

          o    general stock market prices and volume fluctuations.

         Domestic and international stock markets often experience extreme price
and volume fluctuations. Market fluctuations, as well as general political and
economic conditions, such as a recession or interest rate or currency rate
fluctuations or political events or hostilities in or surrounding Israel, could
adversely affect the market price of our ordinary shares.

         In the past, securities class action litigation has often been brought
against a company following periods of volatility in the market price of its
securities. We may in the future be the target of similar litigation. Securities
litigation could result in substantial costs and divert management's attention
and resources.

We do not expect to distribute cash dividends.

         We do not anticipate paying cash dividends in the foreseeable future.
Our Board of Directors will decide whether to declare any cash dividends in the
future based on the conditions then existing, including our earnings and
financial condition. According to the Israeli Companies Law, a company may
distribute dividends out of its profits (within the meaning of the Israeli
Companies Law), so long as the company reasonably believes that such dividend
distribution will not prevent the company from paying all its current and future
debts.

Compliance  with  changing   regulation  of  corporate   governance  and  public
disclosure may result in additional expenses.

         Changing laws, regulations and standards relating to corporate
governance and public disclosure, including the Sarbanes-Oxley Act of 2002, new
Securities and Exchange Commission regulations and NASDAQ Stock Market rules,
are creating uncertainty for companies such as ours. We are committed to
maintaining high standards of corporate governance and public disclosure. As a
result, we intend to invest reasonably necessary resources to comply with
evolving standards, and this investment may result in increased general and
administrative expenses and a diversion of management time and attention from
revenue-generating activities to compliance activities, which could harm our
operating results and business prospects.

Risks Relating to Operations in Israel

Conducting business in Israel entails special risks.

         We are incorporated under the laws of, and our executive offices and
research and development facilities are located in, the State of Israel.
Although most of our sales are made to customers outside Israel, we are directly
influenced by the political, economic and military conditions affecting Israel.
Specifically, we could be adversely affected by any major hostilities involving
Israel, a full or partial mobilization of the reserve forces of the Israeli
army, the


                                       15






interruption or curtailment of trade between Israel and its present trading
partners, or a significant downturn in the economic or financial condition of
Israel.

         Since the establishment of the State of Israel in 1948, a number of
armed conflicts have taken place between Israel and its Arab neighbors, and a
state of hostility, varying from time to time in intensity and degree, has led
to security and economic problems for Israel. Since September 2000, there has
been a marked increase in violence, civil unrest and hostility, including armed
clashes, between the State of Israel and the Palestinians, and acts of terror
have been committed inside Israel and against Israeli targets in the West Bank
and Gaza. These developments have adversely affected the regional peace process,
placed the Israeli economy under significant stress, and have negatively
influenced Israel's relationship with several Arab countries. In August 2005,
Israel evacuated all Israeli settlements in the Gaza Strip and four settlements
in the West Bank. The implications of this action cannot at this time be
foreseen. Any future armed conflict, political instability or violence in the
region may have a negative effect on our business condition, harm our results of
operations and adversely affect our share price.

         Furthermore, there are a number of countries that restrict business
with Israel or Israeli companies. Restrictive laws or policies of those
countries directed towards Israel or Israeli businesses had, and may in the
future continue to have, an adverse impact on our operations, our financial
results or the expansion of our business. No predictions can be made as to
whether or when a final resolution of the area's problems will be achieved or
the nature thereof and to what extent the situation will impact Israel's
economic development or our operations.

Political   trade   relations   could   limit  our   ability   to  sell  or  buy
internationally.

         We could be adversely affected by the interruption or reduction of
trade between Israel and its trading partners. Some countries, companies and
organizations continue to participate in a boycott of Israeli firms and others
doing business with Israel or with Israeli companies. To date, these measures
have not had a material adverse affect on our business. However, there can be no
assurance that restrictive laws, policies or practices towards Israel or Israeli
businesses will not have an adverse impact on our business.

Our results of operations  may be negatively  affected by the  obligation of our
personnel to perform military service.

         Many of our directors, officers and employees in Israel are obligated
to perform annual reserve duty in the Israeli Defense Forces and may be called
for active duty under emergency circumstances at any time. If a military
conflict or war arises, these individuals could be required to serve in the
military for extended periods of time. Our operations could be disrupted by the
absence for a significant period of one or more of our executive officers or key
employees or a significant number of other employees due to military service.
Any disruption in our operations could adversely affect our business.

The economic conditions in Israel have not been stable in recent years.

         In recent years Israel has been going through a period of recession in
economic activity, resulting in low growth rates and growing unemployment.
Although economic activity in Israel has improved recently, our operations could
be adversely affected if the economic conditions in


                                       16






Israel begin to deteriorate once again. In addition, due to significant economic
measures proposed by the Israeli Government, there have been several general
strikes and work stoppages in 2003 and 2004, affecting all banks, airports and
ports. These strikes have had an adverse effect on the Israeli economy and on
business, including our ability to deliver products to our customers.

Our  financial  results may be  adversely  affected by  inflation  and  currency
fluctuations.

         Since we report our financial results in dollars, fluctuations in rates
of exchange between the dollar and non-dollar currencies may affect our results
of operations. The majority of our expenses are paid in NIS (primarily salaries)
and are influenced by the timing of, and the extent to which, any increase in
the rate of inflation in Israel over the rate of inflation in the United States
is not offset by the devaluation of the NIS in relation to the dollar. We
believe that the rate of inflation in Israel has not had a material adverse
effect on our business to date. However, our dollar costs in Israel will
increase if inflation in Israel exceeds the devaluation of the NIS against the
dollar or if the timing of such devaluation lags behind inflation in Israel.
Over time, the NIS has been devalued against the dollar, generally reflecting
inflation rate differentials. We cannot predict any future trends in the rate of
inflation in Israel or the rate of devaluation of the NIS against the dollar. If
the dollar cost of our operations in Israel increases, our dollar measured
results of operations will be adversely affected. Likewise, our operations could
be adversely affected if we are unable to guard against currency fluctuations in
the future.

The government programs and tax benefits we currently  participate in or receive
require us to meet several  conditions  and may be  terminated or reduced in the
future.

         We have benefited from certain Israeli Government grants, programs and
tax benefits. To remain eligible for these grants, programs and tax benefits, we
must comply with certain conditions, including making specified investments in
fixed assets from our own equity and paying royalties with respect to grants
received. In addition, some of these programs restrict our ability to
manufacture particular products and to transfer particular technology outside of
Israel. If we do not meet these conditions in the future, the benefits we
received could be canceled and we may have to refund payments previously
received under these programs or pay increased taxes. The Government of Israel
has reduced the benefits available under these programs in recent years and
these programs and tax benefits may be discontinued or curtailed in the future.
We intend to apply to the Office of the Chief Scientist for grants in the second
half of 2005 and in 2006; however, there can be no assurance that we will be
able to obtain any such grants in the future.

Service and  enforcement  of legal  process on us and our directors and officers
may be difficult to obtain.

         Service of process upon our directors and officers and the Israeli
experts named herein, most of whom reside outside the United States, may be
difficult to obtain within the United States. Furthermore, since substantially
all of our assets, most of our directors and officers and the Israeli experts
named herein are located outside the United States, any judgment obtained in the
United States against us or these individuals or entities may not be collectible
within the United States.

         There is doubt as to the enforceability of civil liabilities under the
Securities Act and the Securities Exchange Act in original actions instituted in
Israel. However, subject to certain time


                                       17






limitations and other conditions, Israeli courts may enforce final judgments of
United States courts for liquidated amounts in civil matters, including
judgments based upon the civil liability provisions of those Acts.

Provisions of Israeli law may delay, prevent or make difficult an acquisition of
us, which could prevent a change of control and  therefore  depress the price of
our shares.

         Provisions of Israeli corporate and tax law may have the effect of
delaying, preventing or making more difficult a merger with, or other
acquisition of, us. This could cause our ordinary shares to trade at prices
below the price for which third parties might be willing to pay to gain control
of us. Third parties who are otherwise willing to pay a premium over prevailing
market prices to gain control of us may be unable or unwilling to do so because
of these provisions of Israeli law.

The rights and  responsibilities of our shareholders are governed by Israeli law
and differ in some respects from the rights and responsibilities of shareholders
under U.S. law.

          We are incorporated under Israeli law. The rights and responsibilities
of holders of our ordinary shares are governed by our memorandum of association,
articles of association and by Israeli law. These rights and responsibilities
differ in some respects from the rights and responsibilities of shareholders in
typical U.S. corporations. In particular, each shareholder of an Israeli company
has a duty to act in good faith in exercising his or her rights and fulfilling
his or her obligations toward the company and other shareholders and to refrain
from abusing his power in the company, including, among other things, in voting
at the general meeting of shareholders on certain matters. Israeli law provides
that these duties are applicable in shareholder votes on, among other things,
amendments to a company's articles of association, increases in a company's
authorized share capital, mergers and interested party transactions requiring
shareholder approval. In addition, a controlling shareholder of an Israeli
company or a shareholder who knows that it possesses the power to determine the
outcome of a shareholder vote or who has the power to appoint or prevent the
appointment of a director or officer in the company has a duty of fairness
toward the company. However, Israeli law does not define the substance of this
duty of fairness. Because Israeli corporate law has undergone extensive revision
in recent years, there is little case law available to assist in understanding
the implications of these provisions that govern shareholder behavior.

                         CAPITALIZATION AND INDEBTEDNESS

         The table below sets forth the capitalization of our company as of June
30, 2005, and as adjusted to give effect to the sale of 937,500 ordinary shares
and warrants to purchase 375,000 ordinary shares to the selling shareholders on
August 10, 2005.

                                                       As of June 30, 2005
                                                   Actual          As Adjusted
                                               ---------------    --------------
                                                      (dollars in thousands)
      Cash and cash equivalents..............      $ 1,750            $ 4,436
                                               ===============    ==============

           Total shareholders' equity........      $ 7,549            $10,235
                                               ---------------    --------------



                                       18








                    REASONS FOR THE OFFER AND USE OF PROCEEDS

         This prospectus relates to the disposition of up to 1,349,500 of our
ordinary shares, of which 937,500 ordinary shares were issued and 412,000
ordinary shares are issuable upon exercise of certain warrants. We are
registering the ordinary shares for disposition by the selling shareholders
pursuant to commitments with the selling shareholders. We will not receive any
of the proceeds from the sale by the selling shareholders of our ordinary
shares. We will, however, receive the proceeds from the exercise of the warrants
if and when they are exercised for cash.

                                MARKET PRICE DATA


         Our ordinary shares are quoted on the NASDAQ Capital Market under the
symbol "MTSL."


Quarterly Stock Information


         The following table sets forth, for each of the full financial quarters
in the years indicated, the high ask and low bid prices of our ordinary shares,
as quoted on the NASDAQ Capital Market.


                                                              High          Low
                                                              ----          ---
          2003
          ----
          First Quarter...............................       $1.05         $0.87
          Second Quarter..............................       $1.90         $0.97
          Third Quarter ..............................       $2.65         $1.65
          Fourth Quarter .............................       $3.56         $2.01

          2004
          ----
          First Quarter ..............................       $4.00         $2.99
          Second Quarter..............................       $3.62         $2.61
          Third Quarter...............................       $2.71         $1.90
          Fourth Quarter..............................       $3.33         $2.08


          2005
          ----
          First Quarter ..............................       $4.09         $3.07
          Second Quarter .............................       $3.95         $2.85
          Third Quarter  .............................       $4.23         $2.93
          Fourth Quarter (through October 25).........       $3.98         $2.96



Monthly Stock Information


         The following table sets forth, for each of the most recent six months,
the high ask and low bid prices of our ordinary shares, as quoted on the NASDAQ
Capital Market.




                                       19









          Month                                         High            Low
          -----                                       -------         -------  
          April 2005...............................    $3.95           $3.05
          May 2005.................................    $3.72           $2.86
          June 2005................................    $3.50           $2.85
          July 2005................................    $3.50           $2.93
          August 2005 .............................    $4.23           $3.01
          September 2005 ..........................    $3.92           $3.25



                              SELLING SHAREHOLDERS

         The registration statement of which this prospectus forms a part covers
up to 1,349,500 ordinary shares. Of such shares, 937,500 shares were issued to
certain of the selling shareholders, and 375,000 shares are issuable upon the
exercise of warrants that were issued to them, pursuant to a Securities Purchase
Agreement dated August 10, 2005. Such warrants have an exercise price of US$4.00
per share, subject to anti-dilution adjustments, and are exercisable from
February 10, 2006 until August 10, 2009. The ordinary shares and warrants were
offered and sold to the selling shareholders in reliance upon the exemption from
securities registration afforded by the provisions of Regulation D promulgated
under the Securities Act of 1933, as amended. The selling shareholders, other
than our President, Mr. Eytan Bar, paid $3.00 per share for the ordinary shares
purchased in the private placement. Mr. Bar purchased 14,000 shares at $3.88 per
share, the closing price of our ordinary shares on the day prior to the closing
of the private placement. We also undertook to effect the registration of the
ordinary shares issued and the ordinary shares issuable upon exercise of the
warrants and to maintain a registration statement in effect in order to allow
the selling shareholders to dispose of these shares from time to time. An
additional 37,000 ordinary shares are issuable pursuant to a warrant issued to
Mr. Avraham Ziv on August 3, 2005 in connection with financial services that he
has provided to our company. These warrants have an exercise price of $4.00 per
share, subject to anti-dilution adjustments, and are exercisable from February
3, 2006 until August 3, 2009. Mr. Ziv has provided financial services to us from
to time during the last five years. Except for the ownership of the ordinary
shares and the warrants, the selling shareholders, other than Messrs. Eytan Bar
and Avraham Ziv and our investment in the employee severance fund managed by
Apex - Provident Funds Management Ltd., have not had any material relationship
with us within the past three years.

         The table below lists the selling shareholders and other information
regarding the beneficial ownership of the ordinary shares by each of the selling
shareholders. The first column lists each of the selling shareholders. The
second and third column list the number and percentage of ordinary shares
beneficially owned by each selling shareholder prior to the offering, based on
each selling shareholder's ownership of the ordinary shares and the warrants, as
of August 10, 2005, assuming full exercise of the warrants held by each selling
shareholder on that date, without regard to any limitations on exercise. The
fourth column lists the ordinary shares being offered by this prospectus by each
of the selling shareholders.

         In accordance with the terms of a registration rights agreement with
the selling shareholders, other than Mr. Ziv, this prospectus generally covers
ordinary shares in an amount

                                       20






equal to the number of ordinary shares issued to the selling shareholders and
issuable upon exercise of the related warrants, determined as if the outstanding
warrants were exercised in full as of the trading day immediately preceding the
date this registration statement was initially filed with the Securities and
Exchange Commission. Because the exercise price of the warrants may be adjusted,
the number of shares that will actually be issued may be more or less than the
number of shares being offered by this prospectus.

         The fifth and sixth columns of the following table assume the sale of
all of the ordinary shares offered by each selling shareholder pursuant to this
prospectus.




                                                                                                            Percentage of
                                 Number of        Percentage of                             Number of         Ordinary
                              Ordinary Shares    Ordinary Shares    Maximum Number of    Ordinary Shares       Shares
                                Beneficially       Beneficially      Ordinary Shares       Beneficially     Beneficially
                               Owned Prior to     Owned Prior to   Offered Pursuant to     Owned After       Owned After
Name of Selling Shareholder       Offering           Offering        this Prospectus         Offering         Offering
---------------------------- ------------------- ----------------- --------------------- ----------------- ----------------

                                                                                                  
Aviv Raiz................       182,427 (1)           3.16%            182,427 (1)              0                0%
Haal - Pension Fund......       178,794 (2)           3.10%            178,794 (2)              0                0%
Apex - Provident Funds
  Management Ltd.(Fund A)       111,279 (3)           1.93%            111,279 (3)              0                0%
Y.A.Z - Investments and
  Assets Ltd. ...........        72,058 (4)           1.25%             72,058 (4)              0                0%
Yuvalim - Pension Fund...        69,020 (5)           1.20%             69,020 (5)              0                0%
Apex - Provident Funds
  Management Ltd.(Fund B)        45,605 (6)           0.79%             45,605 (6)              0                0%
Yuvalim - Study Fund.....        43,645 (7)           0.76%             43,645 (7)              0                0%
D.I.M - Risk Management
  Ltd....................        36,484 (8)           0.64%             36,484 (8)              0                0%
Nadav Henefeld...........        62,544 (9)           1.09%             36,484 (9)           26,060              0.45%
Shulamit Nissim..........        36,484 (10)          0.64%             36,484 (10)             0                0%
Moshe Nubelman...........        36,484 (11)          0.64%             36,484 (11)             0                0%
Alex Rabinovitch.........        48,384 (12)          0.84%             36,484 (12)          11,900              0.21%
Dan Rimoni ..............        36,484 (13)          0.64%             36,484 (13)             0                0%
Lior Salansky............        42,484 (14)          0.74%             36,484 (14)           6,000              0.10%
Amir Shoham..............        36,484 (15)          0.64%             36,484 (15)             0                0%
Ben-Zion Weiner..........        36,484 (16)          0.64%             36,484 (16)             0                0%
Keren Yehuda ............        36,484 (17)          0.64%             36,484 (17)             0                0%
Negev - Central Funds for
  Severance Pay A........        62,920 (18)          1.10%             36,120 (18)          26,800              0.47%
I.B.I - Menayot .........        80,400 (19)          1.40%             30,100 (19)          50,300              0.88%
Apex - Provident Funds
  Management Ltd. (Fund C)       25,522 (20)          0.45%             25,522 (20)             0                0%
Eytan Bar ...............       128,975 (21)          2.25%             19,600 (21)         109,375              1.91%
Hana and Reuven Cohen ...        18,242 (22)          0.32%             18,242 (22)             0                0%
Ronen Kantor ............        19,242 (23)          0.34%             18,242 (23)           1,000              0.02%
Teleseffer.com Ltd.......        18,242 (24)          0.32%             18,242 (24)             0                0%
Doron Turgeman ..........        18,242 (25)          0.32%             18,242 (25)             0                0%
Y.S. Tami Trade Ltd......        18,242 (26)          0.32%             18,242 (26)             0                0%
Yecheskel Samra .........        18,060 (27)          0.32%             18,060 (27)             0                0%
Gil Shabtai .............        12,110 (28)          0.21%             12,110 (28)             0                0%


                                       21


Moshe Shabtai ...........        12,110 (29)          0.21%             12,110 (29)             0                0%
Avraham Ziv..............        55,000 (30)          0.95%             37,000 (30)          18,000              0.31%


------------

(1)    Includes 52,122 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(2)    Includes 51,084 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Marko Touil
       exercises sole voting and dispositive powers over the shares held by the
       Haal-Pension Fund.

(3)    Includes 31,794 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Each of Messrs. Rami
       Shalom and Eytan Yekutial may exercise voting and dispositive powers over
       the shares held by Apex-Provident Funds Management Ltd.

(4)    Includes 20,588 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Yehuda Zadike
       exercises sole voting and dispositive powers over the shares held by
       D.I.M-Risk Management Ltd.

(5)    Includes 19,720 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Marko Touil
       exercises sole voting and dispositive powers over the shares held by the
       Yuvalim-Pension Fund.

(6)    Includes 13,030 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Each of Messrs. Rami
       Shalom and Eytan Yekutial may exercise voting and dispositive powers over
       the shares held by Apex-Provident Funds Management Ltd.

(7)    Includes 12,470 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Marko Touil
       exercises sole voting and dispositive powers over the shares held by the
       Yuvalim-Study Fund.

(8)    Includes 10,424 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Ms. Sagit Rabinovitch
       exercises sole voting and dispositive powers over the shares held by
       D.I.M - Risk Management Ltd.

(9)    Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(10)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(11)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(12)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(13)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(14)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(15)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(16)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(17)   Includes 10,424 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(18)   Includes 10,320 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Ami Sudi exercises
       sole voting and dispositive powers over 

                                       22


       the shares held by Negev-Central Funds for Severance Pay A.

(19)   Includes 8,600 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Hertzel Babaiov
       exercises sole voting and dispositive powers over the shares held by
       I.B.I-Menayot. I.B.I-Menayot has informed us in writing that it is an
       affiliate of a registered broker-dealer. I.B.I-Menayot has further
       informed us in writing that it acquired its ordinary shares and warrants
       exercisable into ordinary shares, that are being registered under the
       registration statement of which this prospectus forms a part, in the
       ordinary course of business and that at the time it purchased such shares
       and warrants it did not have any agreements, plans or understandings,
       directly or indirectly, with any person to distribute the shares or
       warrants.

(20)   Includes 7,292 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Each of Messrs. Rami
       Shalom and Eytan Yekutial may exercise voting and dispositive powers over
       the shares held by Apex-Provident Funds Management Ltd.

(21)   Includes 5,600 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006 and 109,375 ordinary
       shares that are issuable upon exercise of options that are exercisable
       within 60 days of the date of this prospectus.

(22)   Includes 5,212 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(23)   Includes 5,212 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(24)   Includes 5,212 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Doron Turgerman
       exercises sole voting and dispositive powers over the shares held by

(25)   Includes 5,212 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(26)   Includes 5,212 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 10, 2006. Mr. Yossi Sasha
       exercises sole voting and dispositive powers over the shares held by Y.S.
       Tami Trade Ltd.

(27)   Includes 5,160 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(28)   Includes 3,460 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(29)   Includes 3,460 ordinary shares issuable upon the exercise of warrants 
       that will become exercisable on February 10, 2006.

(30)   Includes 37,000 ordinary shares issuable upon the exercise of warrants
       that will become exercisable on February 3, 2006. Mr. Avraham Ziv has
       informed us in writing that he is an affiliate of a registered
       broker-dealer. Mr. Ziv has further informed us in writing that he
       acquired the ordinary shares and warrants exercisable into ordinary
       shares, that are being registered under the registration statement of
       which this prospectus forms a part, in the ordinary course of business
       and that at the time he purchased such shares and warrants he did not
       have any agreements, plans or understandings, directly or indirectly,
       with any person to distribute the shares or warrants.

         OFFER STATISTICS, EXPECTED TIME TABLE AND PLAN OF DISTRIBUTION

         We are registering the ordinary shares issued to the selling
shareholders and issuable upon exercise of the warrants to permit the resale of
these ordinary shares by the holders of the ordinary shares and the warrants
from time to time after the date of this prospectus. We will not receive any of
the proceeds from the sale by the selling shareholders of the ordinary shares.
We will bear all fees and expenses incident to our obligation to register the
ordinary shares.

                                       23






         The selling shareholders may sell all or a portion of the ordinary
shares beneficially owned by them and offered hereby from time to time directly
or through one or more underwriters, broker-dealers or agents. If the ordinary
shares are sold through underwriters or broker-dealers, the selling shareholders
will be responsible for underwriting discounts or commissions or agent's
commissions. The ordinary shares may be sold in one or more transactions at
fixed prices, at prevailing market prices at the time of the sale, at varying
prices determined at the time of sale, or at negotiated prices. These sales may
be effected in transactions, which may involve crosses or block transactions, on
any national securities exchange or quotation service on which the securities
may be listed or quoted at the time of sale; in the over-the-counter market; in
transactions otherwise than on these exchanges or systems or in the
over-the-counter market; through the writing of options, whether such options
are listed on an options exchange or otherwise; ordinary brokerage transactions
and transactions in which the broker-dealer solicits purchasers; block trades in
which the broker-dealer will attempt to sell the shares as agent but may
position and resell a portion of the block as principal to facilitate the
transaction; purchases by a broker-dealer as principal and resale by the
broker-dealer for its account; an exchange distribution in accordance with the
rules of the applicable exchange; privately negotiated transactions; short
sales. Broker-dealers may agree with the selling security holders to sell a
specified number of such shares at a stipulated price per share; a combination
of any such methods of sale; and any other method permitted pursuant to
applicable law.

         If the selling shareholders effect such transactions by selling
ordinary shares to or through underwriters, broker-dealers or agents, such
underwriters, broker-dealers or agents may receive commissions in the form of
discounts, concessions or commissions from the selling shareholders or
commissions from purchasers of the ordinary shares for whom they may act as
agent or to whom they may sell as principal (which discounts, concessions or
commissions as to particular underwriters, broker-dealers or agents may be in
excess of those customary in the types of transactions involved). In connection
with sales of the ordinary shares or otherwise, the selling shareholders may
enter into hedging transactions with broker-dealers, which may in turn engage in
short sales of the ordinary shares in the course of hedging in positions they
assume. The selling shareholders may also sell ordinary shares short and deliver
ordinary shares covered by this prospectus to close out short positions. The
selling shareholders may also loan or pledge ordinary shares to broker-dealers
that in turn may sell such shares.

         The selling shareholders may pledge or grant a security interest in
some or all of the warrants or ordinary shares owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured
parties may offer and sell the ordinary shares from time to time pursuant to
this prospectus or any amendment to this prospectus under Rule 424(b)(3) or
other applicable provision of the Securities Act of 1933, as amended, amending,
if necessary, the list of selling shareholders to include the pledgee,
transferee or other successors in interest as selling shareholders under this
prospectus. The selling shareholders also may transfer and donate the ordinary
shares in other circumstances in which case the transferees, donees, pledgees or
other successors in interest will be the selling beneficial owners for purposes
of this prospectus.

         The selling shareholders and any broker-dealer participating in the
distribution of the ordinary shares may be deemed to be "underwriters" within
the meaning of the Securities Act, and

                                       24





any commission paid, or any discounts or concessions allowed to, any such
broker-dealer may be deemed to be underwriting commissions or discounts under
the Securities Act. At the time a particular offering of the ordinary shares is
made, a prospectus supplement, if required, will be distributed which will set
forth the aggregate amount of ordinary shares being offered and the terms of the
offering, including the name or names of any broker-dealers or agents, any
discounts, commissions and other terms constituting compensation from the
selling shareholders and any discounts, commissions or concessions allowed or
re-allowed or paid to broker-dealers.

         Under the securities laws of some states, the ordinary shares may be
sold in such states only through registered or licensed brokers or dealers. In
addition, in some states the ordinary shares may not be sold unless such shares
have been registered or qualified for sale in such state or an exemption from
registration or qualification is available and is complied with.

         There can be no assurance that any selling shareholder will sell any or
all of the ordinary shares registered pursuant to the registration statement, of
which this prospectus forms a part.

         The selling shareholders and any other person participating in such
distribution will be subject to applicable provisions of the Securities Exchange
Act of 1934, as amended, and the rules and regulations thereunder, including,
without limitation, Regulation M of the Exchange Act, which may limit the timing
of purchases and sales of any of the ordinary shares by the selling shareholders
and any other participating person. Regulation M may also restrict the ability
of any person engaged in the distribution of the ordinary shares to engage in
market-making activities with respect to the ordinary shares. All of the
foregoing may affect the marketability of the ordinary shares and the ability of
any person or entity to engage in market-making activities with respect to the
ordinary shares.

         We will pay all expenses of the registration of the ordinary shares
pursuant to the registration rights agreement, including, without limitation,
Securities and Exchange Commission filing fees and expenses of compliance with
state securities or "blue sky" laws; provided, however, that a selling
shareholder will pay all underwriting discounts and selling commissions, if any.
We will indemnify the selling shareholders against liabilities, including some
liabilities under the Securities Act, in accordance with the registration rights
agreement, or the selling shareholders will be entitled to contribution. We may
be indemnified by the selling shareholders against civil liabilities, including
liabilities under the Securities Act, that may arise from any written
information furnished to us by the selling shareholder specifically for use in
this prospectus, in accordance with the related registration rights agreement,
or we may be entitled to contribution.

         Once sold under the registration statement, of which this prospectus
forms a part, the ordinary shares will be freely tradable in the hands of
persons other than our affiliates.

                    EXPENSES ASSOCIATED WITH THE REGISTRATION

         We have agreed to bear all expenses relating to the registration of the
ordinary shares registered pursuant to the registration statement of which this
prospectus is a part. We estimate these expenses to be approximately $52,000,
which include the following categories of expenses:


                                       25





         SEC registration fee.....................................      $ 595.64
         Printing, Edgar and photocopying fees ...................      3,000.00
         Legal fees and expenses..................................     25,000.00
         Accounting fees and expenses.............................     22,000.00
         Transfer agent and registrar fees and expenses...........      1,000.00
         Miscellaneous expenses                                           404.36
                  Total Expenses..................................   $ 52,000.00


                 FOREIGN EXCHANGE CONTROLS AND OTHER LIMITATIONS

         Non-residents of Israel who purchase our ordinary shares may freely
convert all amounts received in Israeli currency in respect of such ordinary
shares, whether as a dividend, as a liquidating distribution or as proceeds from
the sale of the ordinary shares, into freely-repatriable non-Israeli currencies
at the rate of exchange prevailing at the time of conversion (provided in each
case that the applicable Israeli income tax, if any, is paid or withheld).
Israeli residents are also eligible to purchase ordinary shares.

         Until May 1998, Israel imposed extensive restrictions on transactions
in foreign currency. These restrictions were largely lifted in May 1998. Since
January 1, 2003, all exchange control restrictions have been eliminated
(although there are still reporting requirements for foreign currency
transactions). Legislation remains in effect, however, pursuant to which
currency controls can be imposed by administrative action at any time.

         The State of Israel does not restrict in any way the ownership or
voting of ordinary shares by non-residents of Israel, except with respect to
subjects of countries that are in a state of war with Israel.

                                     EXPERTS


         Our consolidated financial statements for the years ended December 31,
2004 and 2003, included in our Annual Report on Form 20-F/A for the year ended
December 31, 2004, have been audited by Kost Forer Gabbay & Kasierer, a member
of Ernst & Young Global, independent registered public accounting firm, as set
forth in their report thereon included therein and incorporated herein by
reference, which as to the year ended December 31, 2004 are based in part on the
report of other auditors. Such consolidated financial statements are
incorporated herein by reference in reliance upon such reports given on the
authority of such firms as experts in accounting and auditing.

         The financial statements of Jusan S.A. for the years ended December 31,
2003 and December 31, 2002 included in our Annual Report on Form 20-F/A for the
year ended December 31, 2004, have been audited by Kost Forer Gabbay & Kasierer,
a member of Ernst & Young Global, independent auditors, as set forth in their
report thereon included therein and incorporated


                                       26







herein by reference. Such financial statements are incorporated herein by
reference in reliance upon such report given on the authority of such firm as
experts in accounting and auditing.

         The financial statements of Jusan S.A. for the years ended December 31,
2004 included in our Annual Report on Form 20-F/A for the year ended December
31, 2004, have been audited by BDO Audiberia, independent auditors, as set forth
in their report thereon included therein and incorporated herein by reference.
Such financial statements are incorporated herein by reference in reliance upon
such report given on the authority of such firm as experts in accounting and
auditing.

         The consolidated financial statements of Business of Teleknowledge
Group Ltd. for the years ended December 30, 2004 and December 31, 2003 included
in our Report on Form 6-K filed in September 2005 with the Securities and
Exchange Commission, have been audited by Kost Forer Gabbay & Kasierer, a member
of Ernst & Young Global, independent auditors, as set forth in their report
thereon included therein and incorporated herein by reference. Such consolidated
financial statements are incorporated herein by reference in reliance upon such
report given on the authority of such firm as experts in accounting and
auditing.


                                  LEGAL MATTERS

         Certain legal matters in connection with the registration of the
ordinary shares hereunder with respect to Israeli law will be passed upon for us
by M. Seligman & Co., Tel-Aviv, Israel, our Israeli counsel.

                                MATERIAL CHANGES


         Except as otherwise described our Annual Report on Form 20-F/A for the
fiscal year ended December 31, 2004 and in our Reports on Form 6-K filed under
the Exchange Act and incorporated by reference herein, no reportable material
changes have occurred since December 31, 2004.


           WHERE YOU CAN BEST FIND MORE INFORMATION; INCORPORATION OF
                        CERTAIN INFORMATION BY REFERENCE


         This prospectus is a part of a registration statement on Form F-3,
Registration No. 333-128225, which we filed with the Securities and Exchange
Commission, or the SEC, under the Securities Act of 1933. As permitted by the
rules and regulations of the SEC, this prospectus does not contain all of the
information contained in the registration statement and the exhibits and
schedules thereto. As such we make reference in this prospectus to the
registration statement and to the exhibits and schedules thereto. For further
information about us and about the securities we hereby offer, you should
consult the registration statement and the exhibits and schedules thereto. You
should be aware that statements contained in this prospectus concerning the
provisions of any documents filed as an exhibit to the registration statement or
otherwise filed with the SEC are not necessarily complete, and in each instance
reference is made to the copy of such document so filed. Each such statement is
qualified in its entirety by such reference.


         We file annual and special reports and other information with the SEC
(Commission File Number 0-28950). These filings contain important information
which does not appear in this

                                       27






prospectus. For further information about us, you may read and copy these
filings at the SEC's public reference room at 100 F Street, N.E., Room 1580,
Washington, D.C. 20549. You may obtain information on the operation of the
public reference room by calling the SEC at 1-800-SEC-0330, and may obtain
copies of our filings from the public reference room by calling (202) 551-8090.

         The SEC allows us to "incorporate by reference" information into this
prospectus, which means that we can disclose important information to you by
referring you to other documents which we have filed or will file with the SEC.
We are incorporating by reference in this prospectus the documents listed below
and all amendments or supplements we may file to such documents, as well as any
future filings we may make with the SEC on Form 20-F under the Exchange Act
before the time that all of the securities offered by this prospectus have been
sold or de-registered.


          o    Our  Annual  Report on Form  20-F/A  for the  fiscal  year  ended
               December 31, 2004;

          o    Our  Reports  on Form 6-K  submitted  to the SEC on July 5, 2005,
               July 20, 2005,  August 19, 2005,  September 9, 2005 (two filings)
               and October 11, 2005; and


          o    The description of our ordinary shares contained in our Amendment
               No. 3 to our Registration Statement on Form F-1, filed on May 20,
               1997.

         In addition, we may incorporate by reference into this prospectus our
reports on Form 6-K filed after the date of this prospectus (and before the time
that all of the securities offered by this prospectus have been sold or
de-registered) if we identify in the report that it is being incorporated by
reference in this prospectus.

         Certain statements in and portions of this prospectus update and
replace information in the above listed documents incorporated by reference.
Likewise, statements in or portions of a future document incorporated by
reference in this prospectus may update and replace statements in and portions
of this prospectus or the above listed documents.

         We shall provide you without charge, upon your written or oral request,
a copy of any of the documents incorporated by reference in this prospectus,
other than exhibits to such documents which are not specifically incorporated by
reference into such documents. Please direct your written or telephone requests
to MER Telemanagement Solutions Ltd., 22 Zarhin Street,Ra'anana 43662, Israel,
Tel:, Attn: Shlomi Hagai, Chief Financial Officer, telephone (972)(9) 762-1777.
You may also obtain information about us by visiting our website at
www.mtsint.com. Information contained in our website is not part of this
prospectus.

         We are an Israeli company and are a "foreign private issuer" as defined
in Rule 3b-4 under the Securities Exchange Act of 1934. As a result, (1) our
proxy solicitations are not subject to the disclosure and procedural
requirements of Regulation 14A under the Exchange Act, (2) transactions in our
equity securities by our officers and directors are exempt from Section 16 of
the Exchange Act, and (3) until November 4, 2002, we were not required to make,
and did not



                                       28






make, our SEC filings electronically, so that those filings are not available on
the SEC's Web site. However, since that date, we have been making all required
filings with the SEC electronically, and these filings are available over the
Internet at the SEC's Web site at http: // www.sec.gov.

                       ENFORCEABILITY OF CIVIL LIABILITIES

         Service of process upon us and upon our directors and officers and the
Israeli experts named in this prospectus, most of whom reside outside the United
States, may be difficult to obtain within the United States. Furthermore,
because substantially all of our assets and substantially all of our directors
and officers are located outside the United States, any judgment obtained in the
United States against us or any of our directors and officers may not be
collectible within the United States.

         We have been informed by our legal counsel in Israel , M. Seligman &
Co., that there is doubt as to the enforceability of civil liabilities under the
Securities Act and the Exchange Act in original actions instituted in Israel.
However, subject to specified time limitations, an Israeli court may declare a
foreign civil judgment enforceable if it finds that:

          o    the judgment was rendered by a court which was,  according to the
               laws of the state of the court, competent to render the judgment,

          o    the judgment is no longer appealable,

          o    the obligation  imposed by the judgment is enforceable  according
               to the rules  relating  to the  enforceability  of  judgments  in
               Israel and the  substance  of the  judgment  is not  contrary  to
               public policy, and

          o    the judgment is executory in the state in which it was given.

         Even if the above conditions are satisfied, an Israeli court will not
enforce a foreign judgment if it was given in a state whose laws do not provide
for the enforcement of judgments of Israeli courts (subject to exceptional
cases) or if its enforcement is likely to prejudice the sovereignty or security
of the State of Israel.

         An Israeli court also will not declare a foreign judgment enforceable
if:

          o    the judgment was obtained by fraud,

          o    there was no due process,

          o    the judgment  was rendered by a court not  competent to render it
               according to the laws of private international law in Israel,

          o    the judgment is at variance with another  judgment that was given
               in the same matter  between  the same  parties and which is still
               valid, or

          o    at the time the action was brought in the foreign court a suit in
               the same matter and between the same parties was pending before a
               court or tribunal in Israel.



                                       29






         We have irrevocably appointed MTS IntegraTRAK, Inc. as our agent to
receive service of process in any action against us in the state and federal
courts sitting in the City of New York, Borough of Manhattan arising out of this
offering or any purchase or sale of securities in connection therewith. We have
not given consent for this agent to accept service of process in connection with
any other claim.

         If a foreign judgment is enforced by an Israeli court, it generally
will be payable in Israeli currency. Judgment creditors must bear the risk of
unfavorable exchange rates.

                                       30










                        MER TELEMANGEMANT SOLUTIONS LTD.






                            1,349,500 ORDINARY SHARES






                          ----------------------------



                                   PROSPECTUS


                          ----------------------------





          You  should  rely only on the  information  incorporated  by
          reference  or  provided  in this  prospectus.  We  have  not
          authorized anyone to provide you with different information.
          We are  not  making  any  offer  to  sell  or buy any of the
          securities  in any state  where the offer is not  permitted.
          You  should  not  assume  that  the   information   in  this
          prospectus  is  accurate  as of any date other than the date
          that appears below.










                                 


                                     PART II
                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 8. Indemnification of Directors and Officers

     Israeli law  provides  that a company  may, if permitted by its articles of
association,  enter  into a  contract  to insure  office  holders  in respect of
liabilities  incurred by the office holder with a respect to an act performed in
his or her capacity as an office holder, as a result of the breach of his or her
duty of care to the company or to another  person,  or as a result of the breach
of his or her duty of loyalty to the company,  provided  that the office  holder
acted in good faith and had  reasonable  cause to believe that the act would not
prejudice  the company.  A company can also insure an office holder for monetary
liabilities  as a result of an act or omission that the office holder  committed
in connection with his or her serving as an office holder.

     In addition,  under Israeli law a company may, if permitted by its articles
of association,  indemnify an office holder for (a) monetary  liability  imposed
upon the office holder in favor of other persons  pursuant to a court  judgment,
including a settlement  or an  arbitrator's  decision  approved by a court;  (b)
reasonable litigation expenses,  including attorney's fees, actually incurred by
the  office  holder as a result of an  investigation  or  proceeding  instituted
against  him by a  competent  authority,  provided  that such  investigation  or
proceeding  concluded  without  the filing of an  indictment  against him or the
imposition  of any  financial  liability  in lieu of  criminal  proceedings,  or
concluded  without  the  filing of an  indictment  against  him and a  financial
liability was imposed on him in lieu of criminal  proceedings  with respect to a
criminal  offense  that  does not  require  proof of  criminal  intent;  and (c)
reasonable litigation expenses,  including attorneys' fees, actually incurred by
the  office  holder or  imposed  upon the  office  holder by a court:  (i) in an
action,  suit or proceeding brought against the office holder by or on behalf of
the company or other persons, (ii) in connection with a criminal action in which
the office holder was acquitted,  or (iii) in connection  with a criminal action
in which the  office  holder  was  convicted  which  does not  require  proof of
criminal  intent;  in each case in connection  with his or her  activities as an
office holder.

     Israeli law provides that a company's  articles of  association  may permit
the company to (a) indemnify an office holder  following a determination to this
effect made by the company after the occurrence of the event in respect of which
the office holder will be indemnified; and (b) undertake in advance to indemnify
an  office  holder,  provided  that  the  undertaking  is  limited  to  types of
occurrences,  which, in the opinion of the company's board of directors, are, at
the time of the undertaking,  foreseeable due to the company's activities and to
an amount or standard that the board of directors  has  determined is reasonable
under the circumstances.

     Israeli  law  also  allows a  company,  if  permitted  by its  articles  of
association, to exculpate an office holder in advance, in whole or in part, from
liability  for  damages  sustained  by a breach of duty of care to the  company.
However, a company may not exculpate a director in advance from his liability to
the  company  with  respect  to a  breach  of his  duty of care in the  event of
distributions.

     These  provisions are  specifically  limited in their scope by Israeli law,
which provides that a company may not indemnify an office holder,  nor exculpate
an office holder, nor enter into an

                                      II-1






insurance  contract  which would  provide  coverage for any monetary  liability,
incurred as a result of certain improper actions.

     The term  "office  holder" of a company  includes  any person  who,  either
formally  or in  substance,  serves  as a  director,  general  manager  or chief
executive  officer,  or other  executive  officer  who  reports  directly to the
general manager or chief executive officer of a company.

     Our Articles of  Association  allow us to insure,  indemnify and exempt our
office holders to the fullest extent permitted by law, subject to the provisions
of the Israeli  Companies Law. We maintain a directors' and officers'  liability
insurance  policy with a per claim and aggregate  coverage  limit of $5 million,
including  legal costs  incurred in Israel.  In addition,  our Audit  Committee,
Board of Directors and  shareholders  resolved to indemnify our office  holders,
pursuant   to  a  standard   indemnification   agreement   that   provides   for
indemnification of an office holder in an amount up to $3 million.

     Pursuant to the terms under  which the  ordinary  shares were issued to the
selling  shareholder,  we agreed to indemnify the selling  shareholders  against
such  liabilities as it may incur as a result of any untrue statement or alleged
untrue statement of a material fact in the registration statement or prospectus,
or any omission to state therein a material  fact required to be stated  therein
or necessary in order to make the statements made, in light of the circumstances
under  which they were  made,  not  misleading.  Such  indemnification  includes
liabilities  under the Securities  Act, the Exchange Act, state  securities laws
and the rules thereunder,  but excludes  liabilities for statements or omissions
that were based on information provided by the selling shareholder,  as to which
the selling shareholder has agreed to indemnify us.

Item 9.  Exhibits

      Exhibit No.    Description of Exhibit
      -----------    ----------------------


         3.1         Memorandum of Association of the Registrant(1)
         3.2         Articles of Association of the Registrant(2)
         4.1         Specimen of Ordinary Share Certificate(3)
         4.2         Securities Purchase Agreement dated August 10, 2005 among 
                     the Registrant and the Investors therein (4)
         4.3         Form of Warrant(5)
         4.4         Registration Rights Agreement dated August 10, 2005 (6)
         4.5         Form of Warrant issued to Mr. Avi Ziv(7)
         5.1         Opinion of M. Seligman & Co. regarding legality of the 
                     securities being registered*
         23.1        Consent of Kost Forer Gabbay & Kasierer, a member of Ernst 
                     & Young Global (relating to Mer Telemanagement Ltd.)
         23.2        Consent of BDO Audiberia Auditores, S.L.
         23.3        Consent of Kost Forer Gabbay & Kasierer, a member of Ernst
                     & Young Global (relating to Jusan, S.A.)
         23.4        Consent of Kost Forer Gabbay & Kasierer, a member of Ernst 
                     & Young Global (relating to Teleknowledge Group Ltd.)
         23.4        Consent of M. Seligman & Co. (contained in Exhibit 5.1)*


                                      II-2







         24.1        Power of Attorney (included in the signature page to the 
                     Registration Statement)*
-------------------

(1)  Filed as Exhibit 3.1 to the Registrant's Registration Statement on Form
     F-1, registration number 333-05814, and incorporated herein by
     reference.
(2)  Filed as Exhibit 3.2 to the Registrant's Registration Statement on Form
     F-1, registration number 333-05814, and incorporated herein by
     reference.
(3)  Filed as Exhibit 4.1 to the Registrant's Registration Statement on Form
     F-1, registration number 333-05814, and incorporated herein by
     reference.
(4)  Filed as Item 1 to the Registrant's Report on Form 6-K for the month of
     August 2005 filed on August 19, 2005, and incorporated herein by reference.
(5)  Filed as Item 3 to the Registrant's Report on Form 6-K for the month of
     August 2005 filed on August 19, 2005, and incorporated herein by reference.
(6)  Filed as Item 2 to the Registrant's Report on Form 6-K for the month of
     August 2005 filed on August 19, 2005, and incorporated herein by reference.
(7)  Filed as Exhibit 4.6 to the Registrant's Registration Statement on Form
     F-3, Registration No. 333-128225, filed on September 9, 2005, and
     incorporated herein by reference
*    Previously filed.



                                      II-3





Item 10.  Undertakings

     The undersigned Registrant hereby undertakes:

          (1) To file,  during  any  period  in which  offers or sales are being
     made, a post-effective amendment to this registration statement:

               (i)  To include any  prospectus  required by Section  10(a)(3) of
                    the Securities Act of 1933;

               (ii) To reflect  in the  prospectus  any facts or events  arising
                    after the effective date of the  registration  statement (or
                    the most recent  post-effective  amendment  thereof)  which,
                    individually  or in the  aggregate,  represent a fundamental
                    change  in the  information  set  forth in the  registration
                    statement.  Notwithstanding  the foregoing,  any increase or
                    decrease  in  volume  of  securities  offered  (if the total
                    dollar  value of  securities  offered  would not exceed that
                    which was registered) and any deviation from the low or high
                    end of the estimated maximum offering range may be reflected
                    in the form of prospectus filed with the Commission pursuant
                    to Rule 424(b) if, in the  aggregate,  the changes in volume
                    and price  represent  no more than 20 percent  change in the
                    maximum   aggregate   offering   price   set  forth  in  the
                    "Calculation  of  Registration  Fee" table in the  effective
                    registration statement; and

               (iii) To include any  material  information  with  respect to the
                    plan  of  distribution  not  previously   disclosed  in  the
                    registration  statement  or  any  material  change  to  such
                    information in the registration statement.

               Provided,  however,  That  paragraphs  (1)(i) and  (1)(ii) do not
               apply  if  the   information   required   to  be  included  in  a
               post-effective  amendment  by those  paragraphs  is  contained in
               periodic reports filed with or furnished to the Commission by the
               Registrant  pursuant  to  Section  13 or 15(d) of the  Securities
               Exchange  Act of 1934 that are  incorporated  by reference in the
               registration statement.

          (2)  That,  for  the  purpose  of  determining   liability  under  the
     Securities Act of 1933, each such post-effective  amendment shall be deemed
     to be a new  registration  statement  relating  to the  securities  offered
     therein,  and the offering of such  securities at that time shall be deemed
     to be the initial bone fide offering thereof.

          (3) To remove from registration by means of a post-effective amendment
     any  of  the  securities  being  registered  which  remain  unsold  at  the
     termination of the offering.

          (4) To file a post-effective  amendment to the registration  statement
     to include any financial  statements  required by Item 8.A. of Form 20-F at
     the start of any delayed  offering or  throughout  a  continuous  offering.
     Financial statements and information otherwise required by Section 10(a)(3)
     of the Act need not be furnished,  provided that the Registrant includes in
     the  prospectus,  by  means  of  a  post-effective   amendment,   financial
     statements required pursuant to



                                      II-4




     this  paragraph  and other  information  necessary to ensure that all other
     information  in the  prospectus is at least as current as the date of those
     financial  statements.  Notwithstanding  the  foregoing,  with  respect  to
     registration statements on Form F-3, a post-effective amendment need not be
     filed to include financial  statements and information  required by Section
     10(a)(3)  of the  Act or  Rule  3-19 of  Regulation  S-K if such  financial
     statements and information are contained in periodic  reports filed with or
     furnished to the  Commission  by the  Registrant  pursuant to Section 13 or
     15(d) of the  Securities  Exchange  Act of 1934  that are  incorporated  by
     reference in the Form F-3.

          (5)  That,  for  the  purposes  of  determining  liability  under  the
     Securities Act of 1933, each filing of the Company's annual report pursuant
     to Section 13(a) or Section  15(d) of the Exchange Act of 1934 (and,  where
     applicable,  each  filing  of an  employee  benefit  plan's  annual  report
     pursuant to Section 15(d) of the  Securities  Exchange Act of 1934) that is
     incorporated by reference in this registration statement shall be deemed to
     be a new registration statement relating to the securities offered therein,
     and the offering of such  securities at that time shall be deemed to be the
     initial bona fide offering thereof.

          (6)  Insofar as  indemnification  for  liabilities  arising  under the
     Securities  Act, may be permitted to  directors,  officers and  controlling
     persons of the Company, pursuant to the foregoing provisions, or otherwise,
     the Company has been  advised  that in the opinion of the  Commission  such
     indemnification is against public policy as expressed in the Securities Act
     and  is,  therefore,   unenforceable.   In  the  event  that  a  claim  for
     indemnification  against  such  liabilities  (other than the payment by the
     registrant  of  expenses  incurred  or  paid  by  a  director,  officer  or
     controlling  person of the  Registrant  in the  successful  defense  of any
     action,  suit or  proceeding)  is  asserted  by such  director,  officer or
     controlling person in connection with the securities being registered,  the
     registrant  will,  unless in the opinion of its counsel the matter has been
     settled  by  controlling  precedent,  submit  to  a  court  of  appropriate
     jurisdiction  the question  whether such  indemnification  by it is against
     public  policy as expressed in the  Securities  Act and will be governed by
     the final adjudication of such issue.


                                      II-5







                                   SIGNATURES


         Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it complies with all of
the requirements for filing on Form F-3 and has duly caused this amendment to
its registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Ra'anana, Israel, on October 26, 2005.            

                                       By: /s/Eytan Bar
                                           ------------
                                           Eytan Bar
                                           President and Chief Executive Officer


         Pursuant to the requirements of the Securities Act, this registration
statement has been signed below by the following persons in the capacities
indicated on October 26, 2005.                                                  

      Signature                          Title
      ---------                          -----

           *                             Chairman of the Board of Directors
      ------------------
      Chaim Mer

      /s/Eytan Bar                       President and Chief Executive Officer
      ------------------
      Eytan Bar

           *                             Chief Accounting and Financial Officer
      ------------------                 and Chief Operating  Officer
      Shlomi Hagai                       

           *                             Director
      ------------------
      Alon Aginsky

           *                             Director
      ------------------
      Isaac Ben-Bassat

           *                             Director
      ------------------
      Orna Berry

           *                             Director
      ------------------
      Yehoshua Gleitman

           *                             Director
      ------------------
      Steven J. Glusband

           *                             Director
      ------------------
      Yaacov Goldman

                                      II-6







      MTS IntegraTRAK, Inc.              Authorized Representative in 
                                           the United States
      By:     *
          --------------
      Name: Harry E. Chesman
      Title:   Controller


* By:    /s/Eytan Bar
         ---------------
         Eytan Bar
         (Attorney-in-fact)




                                      II-7